共 100 条
- [1] Pizzirani S(2015)Definition, classification, and pathophysiology of canine glaucoma Vet Clin North Am Small Anim Pract 45 1127-1157
- [2] Alario AF(2015)Medical treatment of primary canine glaucoma Vet Clin North Am Small Anim Pract 45 1235-1259
- [3] Strong TD(2015)Canine secondary glaucomas Vet Clin North Am Small Anim Pract 45 1335-1364
- [4] Pizzirani S(2012)Randomized clinical trial of the efficacy and safety of preservative-free tafluprost and timolol in patients with open-angle glaucoma or ocular hypertension Am J Ophthalmol 153 1187-1196
- [5] Pumphrey S(2013)Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma Clin Ophthalmol 7 7-14
- [6] Chabi A(2011)Tafluprost for the reduction of interocular pressure in open angle glaucoma and ocular hypertension Ophthalmol Eye Dis 3 13-19
- [7] Varma R(2016)Prospective observational post-marketing study of tafluprost 0.0015%/timolol 0.5% combination ophthalmic solution for glaucoma and ocular hypertension: short-term efficacy and safety Ophthalmol Ther 5 191-206
- [8] Tsai JC(2014)Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the J Ocul Pharmacol Ther 30 468-475
- [9] Lupinacci R(2015)Intraocular pressure decrease with preservative-free fixed and unfixed combination of tafluprost and timolol in pseudoexfoliative glaucoma Curr Med Res Opin 31 13-16
- [10] Pigeon J(2014)Fixed-dose combination of tafluprost and timolol in the treatment of open-angle glaucoma and ocular hypertension: comparison with other fixed-combination products Adv Ther 31 932-944